Status:
COMPLETED
Feasibility of Ripple Health Smart Pill Caps in Clinical Settings
Lead Sponsor:
Manan Shukla
Conditions:
Chronic Disease
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to determine whether Ripple Health Smart Medicine Bottle Caps can allow for better interface medication administration than traditional pill bottles. A secondary goal o...
Detailed Description
Approximately 133 million or six out of ten patients are affected by at least one chronic disease such as heart disease, stroke or diabetes (National Health Council). Although these diseases can be tr...
Eligibility Criteria
Inclusion
- All patients in the clinic above the age of 18 with the ability to consent and have a prescribed medication from the clinic will be asked to participate in the study. All patients also must be proficient in English.
- Patients who are minors are required do have at least 1 capable guardian/parent who will be administering the medication and using the pill bottle.
- This will be determined by the physician, as he has seen such a patient in the past. The physician will determine whether the patient has a physical or mental condition and thus will be excluded from the study.
- The parent of the minor must also be mentally and physically capable of opening the pill bottle.
- Patients are also required to have wifi-connectivity in order to consent.
Exclusion
- All subjects in the study must be above the age of 18- whether they are the patients themselves, or the parents of the patients. All age related criteria about the patient can be determined from an EHR service that is already being used in the clinic
- Patients who cannot use the bottle due to a physical(cannot open the bottle) or mental condition will not be allowed to participate in the study. This will be determined by the physician, as he has seen such a patient in the past. The physician will determine whether the patient has a physical or mental condition and thus will be excluded from the study.
- Patients above 18 who are unable to consent will be excluded from the study. The ability to consent will be determined through the physician, who will decide whether the patient is able to consent to the study. The physician, who has worked with the patient significantly in the past, will be able to determine whether the patient is able to consent to the study.
- Minors whose guardian/parent is unable to consent will be excluded from the study. This will be determined by the physician, as he has seen such a patient in the past. The physician will determine whether the patient has a physical or mental condition and thus will be excluded from the study. The parents of the minors must also be able to physically open the pill bottle.
- Minors who are mentally and physically incapable will be excluded from the study. This will be determined by the physician, as he has seen such a patient in the past. The physician will determine whether the patient has a physical or mental condition and thus will be excluded from the study.
- Patients without wifi connectivity will be excluded from the study. We can determine patients who have wifi-connectivity by asking the patient if he/she has connectivity in his/her residence. Patients who have limited English proficiency will be excluded from the study. This can be determined through conversation with the patient. If the patient shows signs of a limited English proficiency, the patient will be excluded from the study.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05192928
Start Date
July 1 2020
End Date
August 15 2020
Last Update
January 14 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy Asthma Sleep Center
Astoria, New York, United States, 11103
2
Allergy Asthma Sleep Center
Brooklyn, New York, United States, 11235
3
Allergy Asthma Sleep Center
New York, New York, United States, 10016
4
Allergy Asthma Sleep Center
Staten Island, New York, United States, 10305